MedPath

Capsaicin

Generic Name
Capsaicin
Brand Names
Capzasin Quick Relief, Capzasin-HP, Castiva Warming, Dendracin Neurodendraxcin, Lidopro, Medi-derm, Medi-derm With Lidocaine, Medrox, Qutenza, Rematex, Xoten-C, Zostrix
Drug Type
Small Molecule
Chemical Formula
C18H27NO3
CAS Number
404-86-4
Unique Ingredient Identifier
S07O44R1ZM

Overview

Capsaicin is most often used as a topical analgesic and exists in many formulations of cream, liquid, and patch preparations of various strengths; however, it may also be found in some dietary supplements. Capsaicin is a naturally-occurring botanical irritant in chili peppers, synthetically derived for pharmaceutical formulations. The most recent capsaicin FDA approval was Qutenza, an 8% capsaicin patch dermal-delivery system, indicated for neuropathic pain associated with post-herpetic neuralgia.

Indication

The capsaicin 8% patch is indicated in the treatment of neuropathic pain associated with post-herpetic neuralgia. There are multiple topical capsaicin formulations available, including creams and solutions, indicated for temporary analgesia in muscle and join pain as well as neuropathic pain.

Associated Conditions

  • Back Pain Lower Back
  • Back pain
  • Bursitis
  • Contusions
  • Inflammatory Reaction caused by Rheumatism
  • Muscle Cramps
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Osteoarthritis (OA)
  • Pain caused by Rheumatism
  • Periarthritis
  • Soft Tissue Injury
  • Tendinitis
  • Acute nonspecific tenosynovitis
  • Articular inflammation

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/02/05
Phase 1
Completed
2025/02/04
Phase 2
Recruiting
2024/12/20
Early Phase 1
Not yet recruiting
2024/08/06
N/A
ENROLLING_BY_INVITATION
2024/07/10
N/A
Not yet recruiting
2024/06/06
Phase 4
Recruiting
University Hospital, Clermont-Ferrand
2023/09/05
Phase 3
Recruiting
2023/08/18
Phase 3
Recruiting
2023/08/09
N/A
Not yet recruiting
2023/05/03
Phase 3
Recruiting
Institut Cancerologie de l'Ouest

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Pharmaceutica North America, Inc.
45861-005
TOPICAL
0.6 g in 120 g
10/27/2011
Koolcare Technology Co., Ltd.
84205-001
TOPICAL
0.25 mg in 1 g
12/30/2024
Home Aide Diagnostics, Inc.
69379-037
TOPICAL
.0375 g in 100 g
12/2/2014
Home Aide Diagnostics, Inc.
69379-001
TOPICAL
0.0375 g in 100 g
7/8/2015
Two Hip Consulting, LLC
76074-152
TOPICAL
.0355 g in 100 mL
1/30/2019
BIO-SANTEE CHEM
69490-020
TOPICAL
0.0375 g in 1 1
1/15/2015
Home Aide Diagnostics, Inc.
69379-013
TOPICAL
0.0357 g in 100 g
7/7/2015
Original Patch Company Inc
69650-002
TOPICAL
.00375 1 in 100 g
3/31/2015
Better Pain Solutions, LLC
69592-001
TOPICAL
0.0375 g in 10 g
3/19/2015
Nationwide Pharmaceutical LLC
69375-006
TOPICAL
0.1 g in 100 g
6/9/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
Authorised
5/15/2009

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
CAPSAICIN MILD CREAM
Wex Pharmaceuticals Inc
02150107
Cream - Topical
0.025 %
3/6/1995
ARTHUR ITIS CREAM
nabtech pharma inc.
02231231
Cream - Topical
0.025 %
9/2/1997
BENEJOINT
lane labs-usa, inc.
02239488
Cream - Topical
0.025 %
1/22/1999
ARTHRITIS EXTRA STRENGTH ROLL-ON LOTION
church & dwight canada corp
02315548
Lotion - Topical
0.035 % / W/W
9/15/2008
CAPSODAN CREAM
odan laboratories ltd
02231073
Cream - Topical
0.05 %
N/A
CAPSAICIN REGULAR CREAM
Wex Pharmaceuticals Inc
02150115
Cream - Topical
0.05 %
3/6/1995
ANTIPHLOGISTINE RUB A-535 CAPSAICIN LIQUID
carter-horner corp.
02238003
Liquid - Topical
0.025 %
11/23/1998
CAPSAICIN CREAM 0.025%
ferndale laboratories inc.
02185717
Cream - Topical
.025 %
11/28/1996
ARTHRITIS PAIN RELIEF
church & dwight canada corp
02486725
Lotion - Topical
0.035 % / W/W
10/28/2019
ARTHRICARE FOR WOMEN MULTI-ACTION
del pharmaceutics (canada) inc.
01935046
Cream - Topical
0.025 %
12/31/1991

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.